'Delivering the National Cancer Plan; What will it take to build innovation-ready cancer services?' follows a roundtable convened by The King's Fund which Professor Adrian Bateman, Chair of the RCPath Cellular Pathology Specialty Advisory Committee, joined with clinical, policy, research and patient advocacy voices to explore how to translate national ambition into real change for people with cancer.
An ageing workforce, increasing burnout and excessive workload, is threatening the sustainability of histopathology. The current average performance for cancer pathway histopathology tests is 68% within ten days against a target of 98%, so much progress is needed.
The College responded to the Government's national cancer plan for England. Pathologists and laboratory staff are vital to the timely diagnosis and treatment of cancer. They are at the forefront of research to develop precise, tailored diagnostics and treatments, such as cancer vaccines, immunotherapies and liquid biopsies, speeding up targeted treatments for individual patients.
Author(s)
